<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005936</url>
  </required_header>
  <id_info>
    <org_study_id>000167</org_study_id>
    <secondary_id>00-H-0167</secondary_id>
    <nct_id>NCT00005936</nct_id>
  </id_info>
  <brief_title>Collection of Liver Tissue for Virologic Studies</brief_title>
  <official_title>Collection of Liver Tissue for Virologic Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      This study will examine liver tissue to investigate the role of viral infections in fulminant&#xD;
      hepatitis, liver failure, and profound bone marrow failure.&#xD;
&#xD;
      All patients who are undergoing liver biopsy or liver transplantation may participate in this&#xD;
      study. For patients undergoing liver biopsy, a small piece of liver tissue will be taken from&#xD;
      the sample collected during the scheduled biopsy. For patients undergoing liver&#xD;
      transplantation, a small piece of tissue will be collected from the diseased liver that is to&#xD;
      be removed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our laboratory has a long-standing interest in viruses that affect the bone marrow. Many such&#xD;
      viruses also may cause hepatitis. One specific syndrome, post-hepatitis aplastic anemia,&#xD;
      suggests that the same agent is responsible for both severe and sometimes fulminant hepatitis&#xD;
      as well as profound bone marrow failure. In investigating the role of viruses in these&#xD;
      diseases, we require small amounts of liver tissue for molecular studies. We request&#xD;
      permission to obtain samples from patients undergoing 1) liver transplantation or 2) liver&#xD;
      biopsy at the time of surgery for purpose of virus discovery, including obtaining control&#xD;
      samples. For liver transplant samples, tissue will be obtained from the removed organ; in&#xD;
      other surgical circumstances, small amounts of tissue will be obtained when the liver is&#xD;
      biopsied for other medical indications. No additional risk to the patient should result from&#xD;
      either procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2000</start_date>
  <completion_date>March 2002</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>50</enrollment>
  <condition>Virus Disease</condition>
  <eligibility>
    <criteria>
      <textblock>
        All patients undergoing open liver biopsy or the removal of liver for purposes of hepatic&#xD;
        transplantation are eligible for participation.&#xD;
&#xD;
        There are no exclusion criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Heart, Lung and Blood Institute (NHLBI)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Naides SJ, Karetnyi YV, Cooling LL, Mark RS, Langnas AN. Human parvovirus B19 infection and hepatitis. Lancet. 1996 Jun 1;347(9014):1563-4. doi: 10.1016/s0140-6736(96)90720-5. No abstract available.</citation>
    <PMID>8684141</PMID>
  </reference>
  <reference>
    <citation>Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Andrews WA, Makowka L, Malatak J, Freese DK, Stock PG, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med. 1988 Aug 18;319(7):393-6. doi: 10.1056/NEJM198808183190702.</citation>
    <PMID>3135496</PMID>
  </reference>
  <reference>
    <citation>Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med. 1997 Apr 10;336(15):1059-64. doi: 10.1056/NEJM199704103361504.</citation>
    <PMID>9091802</PMID>
  </reference>
  <verification_date>March 2002</verification_date>
  <study_first_submitted>July 6, 2000</study_first_submitted>
  <study_first_submitted_qc>July 6, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2000</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Fulminant Hepatitis</keyword>
  <keyword>Parvovirus</keyword>
  <keyword>Hepatitis</keyword>
  <keyword>Biopsy</keyword>
  <keyword>Control</keyword>
  <keyword>Liver Biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

